- Home
- MLYS vs BWLP Comparison
MLYS vs BWLP Comparison
Compare MLYS & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | BWLP |
|---|---|---|
| Founded | 2019 | 1935 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLYS | BWLP |
|---|---|---|
| Price | $23.86 | $16.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.67 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 381.6K |
| Earning Date | 03-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 9.30% |
| EPS Growth | ★ 37.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.44 | $7.86 |
| 52 Week High | $47.65 | $18.84 |
Technical Indicators
Market Signals| Indicator | MLYS | BWLP |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 50.28 |
| Support Level | $13.42 | $13.43 |
| Resistance Level | $31.09 | $16.46 |
| Average True Range (ATR) | 1.75 | 0.49 |
| MACD | -0.24 | -0.13 |
| Stochastic Oscillator | 15.31 | 52.86 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About BWLP BW LPG Limited
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.